Sodium in Medical Technology
Navigation Links
Sodium in Medical Technology
... the second of two Phase III clinical trials of sodium oxybate (JZP-6) for the treatment of ... this international, placebo-controlled trial of sodium oxybate to treat fibromyalgia achieved its key ... randomized, double-blind fibromyalgia study, sodium oxybate significantly decreased pain and fatigue ...
... efficacy study demonstrating that EUFLEXXA(R) (1% sodium hyaluronate) was effective at decreasing the pain ... About EUFLEXXA (R) EUFLEXXA(R) (1% sodium hyaluronate) is the first non-avian derived * ... DEGARELIX for injection and EUFLEXXA(R) (1% sodium hyaluronate). Ferring Pharmaceuticals ...
... exclusive marketing and distribution rights to sodium oxybate for fibromyalgia in Europe and many other countries outside North America. About sodium Oxybate sodium oxybate is ...
... first of two Phase III pivotal clinical trials of sodium oxybate (JZP-6) for the treatment of ... its primary endpoints, demonstrating that sodium oxybate significantly decreased pain and fatigue, ... randomized to one of three treatment arms: sodium oxybate 4.5 ...
... of the Knee, showing that EUFLEXXA(R) (1% sodium hyaluronate), a highly pure non-avian high ... (n=35) groups. About EUFLEXXA EUFLEXXA (1% sodium hyaluronate) is the first non-avian ... Treatment Considerations EUFLEXXA(R) (1% sodium hyaluronate) is indicated for the treatment ...
... clinical trial of its lead drug candidate trans sodium crocetinate (TSC). The trial, designated ... the legs. Additional Clinical Trials with Trans sodium Crocetinate (TSC): Also in 2008, Diffusion ... be collected and evaluated. About Trans sodium Crocetinate (TSC): TSC is a proprietary small ...
... completed in 2005, fibromyalgia patients taking sodium oxybate, the active ingredient in JZP-6, achieved ... one of the two pivotal Phase III trials. sodium oxybate is approved by the FDA for the treatment ... loss of muscle tone) in patients with narcolepsy. sodium oxybate has not been approved for the treatment ...
... In TRIUMPH-1: Discussion of Inhaled Treprostinil sodium in Patients with PAH, Dr. Vallerie McLaughlin, ... sessions per day. The TRIUMPH-1 (TReprostinil sodium Inhalation Used in the Management of Pulmonary ... that intravenously administered treprostinil sodium (Remodulin(R)) decreased the presence of a ...
... hours compared to sumatriptan 85 mg or naproxen sodium 500 mg alone. In addition, Treximet provided more ... hours compared to sumatriptan 85 mg, naproxen sodium 500 mg or placebo alone. Importantly, in these ... agent. Therefore, sumatriptan and naproxen sodium contribute to the relief of migraine through ...
... the ability of ranolazine to inhibit the late sodium current at therapeutic levels. Published data ... suggests that during ischemic episodes excess sodium can flow into cardiac cells through sodium channels. This excess sodium can lead to calcium overload, which in turn can ...
... doses of oral dabigatran etexilate with warfarin sodium (target INR 2.0-3.0) in patients ... risk factor for stroke and, despite warfarin sodium being available as an effective treatment option, ... of dabigatran etexilate with open label warfarin sodium in patients with non-valvular atrial fibrillation ...
... studies of its once- daily topical diclofenac sodium patch to treat mild to moderate pain. One of the ... the subjects randomized to receive the diclofenac sodium patch and the other half to receive placebo. ... of a topical patch formulation of diclofenac sodium in patients with acute musculoskeletal pain. ...
... hydrochloride injection) effectively raises serum sodium concentration ([Na+]) and is well-tolerated among ... condition that occurs when the body's sodium level falls below normal. The efficacy and safety ... VAPRISOL can safely and effectively raise serum sodium levels in patients with underlying conditions ...
... showed a significant increase in serum sodium concentrations in patients with hyponatremia -- a ... condition that occurs when the body's sodium level falls below normal. "This study ... effect, known as "aquaresis," increases serum sodium levels and helps to restore salt and water ...
... These data come on the heels of our recently announced positive ecabet sodium Phase 2b study results in ISTA's dry eye franchise. We will analyze the ... in this press release related to the anticipated design of future ecabet sodium studies, the results of future or ongoing studies with ISTA's low-dose ...
... should not be administered to patients with known hypersensitivity to sodium phenylbutyrate or any component of this preparation. The most common ... or severe renal insufficiency, and in clinical states where there is sodium retention with edema. Use caution when administering to patients with ...
... to patients who complete either of the two pivotal Phase III trials. sodium oxybate is the active ingredient in Xyrem(R), a Jazz Pharmaceuticals ... cataplexy (the sudden loss of muscle tone) in patients with narcolepsy. sodium oxybate has not been approved for the treatment of fibromyalgia. About ...
... from the Company's two Phase III clinical trials of Xibrom(TM) (bromfenac sodium ophthalmic solution) QD (once- daily) formulation, a new formulation of ... twice-daily formulation of Xibrom was as effective as both diclofenac sodium 0.1% ophthalmic solution or ketorolac tromethamine 0.5% ophthalmic ...
... (6%). Do not administer to patients with known hypersensitivity to sodium phenylacetate or sodium benzoate. Acute symptomatic hyperammonemia should ... or severe renal insufficiency, and in clinical states where there is sodium retention with edema. Use caution when administering to patients with ...
... the effect of CD-NP on systemic blood pressure, urinary flow rate, urinary sodium excretion, serum potassium, renal function and cGMP, a secondary messenger ... baseline (125%, 53%, 30% and 230% average change, respectively), increased sodium excretion versus baseline (28%, 138%, 55% and 158% average change, ...
... the effect of CD-NP on systemic blood pressure, urinary flow rate, urinary sodium excretion, serum potassium, renal function and cGMP, a secondary messenger ... baseline (125%, 53%, 30% and 230% average change, respectively), increased sodium excretion versus baseline (28%, 138%, 55% and 158% average change, ...
... of the brain, but may become more generalised; the symptoms vary according to the affected areas. Nerve impulses are triggered via voltage-gated sodium channels in the nerve cell membrane. Treatment of partial-onset seizures, the most common type of epilepsy, presents a constant challenge - up ...
... Orleans by Isis and its collaborators. Isis' scientists presented new preclinical data on ISIS-SGLT2Rx showing a robust and sustained reduction in sodium dependent glucose co-transporter type 2 (SGLT2) levels that resulted in a significant reduction in blood glucose levels in multiple animal species. ...
... results in constriction and increasing blood pressure. In addition, angiotensin II stimulates the release of another hormone that causes enhanced sodium and chloride (salt) retention, with a resultant increase in vascular water retention and blood volume that also contributes to an elevation in blood ...
... results in constriction and increasing blood pressure. In addition, angiotensin II stimulates the release of another hormone that causes enhanced sodium and chloride (salt) retention, with a resultant increase in vascular water retention and blood volume that also contributes to an elevation in blood ...
Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia
... -- Jazz Pharmaceuticals' (Nasdaq: JAZZ ) sodium oxybate (JZP-6) demonstrated statistically ... FDA or other regulatory authorities for use of sodium oxybate in the treatment of fibromyalgia. ... physical function. "The data showed that sodium oxybate improves the key symptoms of ...Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
... has been shown to involve the modulation of sodium channel activity in the nervous system. sodium channels play a crucial role in regulating the ... system to help nerve cells communicate. Sometimes sodium channels are abnormally overactive and nerve ...... efficacy study demonstrating that EUFLEXXA(R) (1% sodium hyaluronate) was effective at decreasing the pain ... About EUFLEXXA (R) EUFLEXXA(R) (1% sodium hyaluronate) is the first non-avian derived * ... DEGARELIX for injection and EUFLEXXA(R) (1% sodium hyaluronate). Ferring Pharmaceuticals ...
ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
... dry eye disease. Patients treated with ecabet sodium achieved a strong positive trend in the objective ... add further support to our belief that ecabet sodium has the ability to treat signs and symptoms of dry eye syndrome. Ecabet sodium may provide advantages over other products used ...... exclusive marketing and distribution rights to sodium oxybate for fibromyalgia in Europe and many other countries outside North America. About sodium Oxybate sodium oxybate is ...
... first of two Phase III pivotal clinical trials of sodium oxybate (JZP-6) for the treatment of ... its primary endpoints, demonstrating that sodium oxybate significantly decreased pain and fatigue, ... randomized to one of three treatment arms: sodium oxybate 4.5 ...
... of the Knee, showing that EUFLEXXA(R) (1% sodium hyaluronate), a highly pure non-avian high ... (n=35) groups. About EUFLEXXA EUFLEXXA (1% sodium hyaluronate) is the first non-avian ... Treatment Considerations EUFLEXXA(R) (1% sodium hyaluronate) is indicated for the treatment ...
China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
... toothache; -- Three drugs, including Diclofenac sodium Suppositories, Paediatric Ibuprofen ... drugs, including Sulfasalazine suppositories and sodium ferulate injection are for the treatment of ... is for the treatment of asthma; -- Pantoprazole sodium injection is for the treatment of canker sores; ...... clinical trial of its lead drug candidate trans sodium crocetinate (TSC). The trial, designated ... the legs. Additional Clinical Trials with Trans sodium Crocetinate (TSC): Also in 2008, Diffusion ... be collected and evaluated. About Trans sodium Crocetinate (TSC): TSC is a proprietary small ...
... completed in 2005, fibromyalgia patients taking sodium oxybate, the active ingredient in JZP-6, achieved ... one of the two pivotal Phase III trials. sodium oxybate is approved by the FDA for the treatment ... loss of muscle tone) in patients with narcolepsy. sodium oxybate has not been approved for the treatment ...
... In TRIUMPH-1: Discussion of Inhaled Treprostinil sodium in Patients with PAH, Dr. Vallerie McLaughlin, ... sessions per day. The TRIUMPH-1 (TReprostinil sodium Inhalation Used in the Management of Pulmonary ... that intravenously administered treprostinil sodium (Remodulin(R)) decreased the presence of a ...
... hours compared to sumatriptan 85 mg or naproxen sodium 500 mg alone. In addition, Treximet provided more ... hours compared to sumatriptan 85 mg, naproxen sodium 500 mg or placebo alone. Importantly, in these ... agent. Therefore, sumatriptan and naproxen sodium contribute to the relief of migraine through ...
Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
... from a Phase I clinical safety study of a novel sodium channel blocker, P-552-02, as a topical therapy ... pursue other potential indications." Epithelial sodium channel blockers, such as P-552-02, are ... utilizing Parion's expertise in epithelial sodium channel blockers. Parion was founded based on ...... the ability of ranolazine to inhibit the late sodium current at therapeutic levels. Published data ... suggests that during ischemic episodes excess sodium can flow into cardiac cells through sodium channels. This excess sodium can lead to calcium overload, which in turn can ...
... doses of oral dabigatran etexilate with warfarin sodium (target INR 2.0-3.0) in patients ... risk factor for stroke and, despite warfarin sodium being available as an effective treatment option, ... of dabigatran etexilate with open label warfarin sodium in patients with non-valvular atrial fibrillation ...
... studies of its once- daily topical diclofenac sodium patch to treat mild to moderate pain. One of the ... the subjects randomized to receive the diclofenac sodium patch and the other half to receive placebo. ... of a topical patch formulation of diclofenac sodium in patients with acute musculoskeletal pain. ...
Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium
... of aspirin therapy, an OTC dose of naproxen sodium did not change the antiplatelet effect profile ... explored the effect of OTC doses of naproxen sodium (220 mg tid) or acetaminophen (1,000 mg qid) on ... supporting the conclusion that naproxen sodium does not change the antiplatelet effect profile ...... hydrochloride injection) effectively raises serum sodium concentration ([Na+]) and is well-tolerated among ... condition that occurs when the body's sodium level falls below normal. The efficacy and safety ... VAPRISOL can safely and effectively raise serum sodium levels in patients with underlying conditions ...
... showed a significant increase in serum sodium concentrations in patients with hyponatremia -- a ... condition that occurs when the body's sodium level falls below normal. "This study ... effect, known as "aquaresis," increases serum sodium levels and helps to restore salt and water ...
... These data come on the heels of our recently announced positive ecabet sodium Phase 2b study results in ISTA's dry eye franchise. We will analyze the ... in this press release related to the anticipated design of future ecabet sodium studies, the results of future or ongoing studies with ISTA's low-dose ...
... should not be administered to patients with known hypersensitivity to sodium phenylbutyrate or any component of this preparation. The most common ... or severe renal insufficiency, and in clinical states where there is sodium retention with edema. Use caution when administering to patients with ...
Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders
... should not be administered to patients with known hypersensitivity to sodium phenylbutyrate or any component of this preparation. The most common ... or severe renal insufficiency, and in clinical states where there is sodium retention with edema. Use caution when administering to patients with ...New Data Show Efficacy of Zebinix(TM) in the Treatment of Epilepsy
... to the affected areas. Nerve impulses are triggered via voltage-gated sodium channels in the nerve cell membrane. About Zebinix(TM) Zebinix(TM) is a novel voltage-gated sodium channel blocker that has been designed to reduce the frequency of ...... to patients who complete either of the two pivotal Phase III trials. sodium oxybate is the active ingredient in Xyrem(R), a Jazz Pharmaceuticals ... cataplexy (the sudden loss of muscle tone) in patients with narcolepsy. sodium oxybate has not been approved for the treatment of fibromyalgia. About ...
Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference
... preclinical data showing that antisense drugs potently reduce levels of sodium dependent glucose transporter type 2 (SGLT2), a key component ... the treatment of chronic diseases." About SGLT2 and ISIS 388626 The sodium dependent glucose transporter type 2 (SGLT2) is the primary mechanism ...Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
... Pre-clinical data have demonstrated the therapeutic potential of sodium sulfide for injection as a treatment for multiple hypoxic/ischemic ... Ikaria is investigating the impact of the sulfide ion, administered as sodium sulfide, in a number of disease models. Preclinical data demonstrate the ...... from the Company's two Phase III clinical trials of Xibrom(TM) (bromfenac sodium ophthalmic solution) QD (once- daily) formulation, a new formulation of ... twice-daily formulation of Xibrom was as effective as both diclofenac sodium 0.1% ophthalmic solution or ketorolac tromethamine 0.5% ophthalmic ...
... (6%). Do not administer to patients with known hypersensitivity to sodium phenylacetate or sodium benzoate. Acute symptomatic hyperammonemia should ... or severe renal insufficiency, and in clinical states where there is sodium retention with edema. Use caution when administering to patients with ...
... the effect of CD-NP on systemic blood pressure, urinary flow rate, urinary sodium excretion, serum potassium, renal function and cGMP, a secondary messenger ... baseline (125%, 53%, 30% and 230% average change, respectively), increased sodium excretion versus baseline (28%, 138%, 55% and 158% average change, ...
... the effect of CD-NP on systemic blood pressure, urinary flow rate, urinary sodium excretion, serum potassium, renal function and cGMP, a secondary messenger ... baseline (125%, 53%, 30% and 230% average change, respectively), increased sodium excretion versus baseline (28%, 138%, 55% and 158% average change, ...
Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
... today it has initiated a Phase I clinical study of a novel diclofenac sodium patch, the Company's lead pain asset. The study will evaluate safety, ... rapidly initiate late-stage efficacy and safety studies of its diclofenac sodium patch in patients with acute musculoskeletal pain. "Topical diclofenac is ...Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skin's Natural Moisture
... to healthy skin by preserving both proteins and lipids during cleansing which is critical for optimal skin health. The formulation is comprised of sodium lauroyl isethionate, a mild cleanser that reduces protein damage, and 100% skin-compatible natural moisturizers, including stearic acid, soybean oil ...... of the brain, but may become more generalised; the symptoms vary according to the affected areas. Nerve impulses are triggered via voltage-gated sodium channels in the nerve cell membrane. Treatment of partial-onset seizures, the most common type of epilepsy, presents a constant challenge - up ...
... Orleans by Isis and its collaborators. Isis' scientists presented new preclinical data on ISIS-SGLT2Rx showing a robust and sustained reduction in sodium dependent glucose co-transporter type 2 (SGLT2) levels that resulted in a significant reduction in blood glucose levels in multiple animal species. ...
Boehringer Ingelheim Unveils Diabetes Pipeline
... Available at: http://www.clinicaltrials.gov/ct2/results?term=BI+1356 . Accessed on: April 30, 2009. (4) Jabbour SA, et al. sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes. ...... results in constriction and increasing blood pressure. In addition, angiotensin II stimulates the release of another hormone that causes enhanced sodium and chloride (salt) retention, with a resultant increase in vascular water retention and blood volume that also contributes to an elevation in blood ...
... results in constriction and increasing blood pressure. In addition, angiotensin II stimulates the release of another hormone that causes enhanced sodium and chloride (salt) retention, with a resultant increase in vascular water retention and blood volume that also contributes to an elevation in blood ...
Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
... DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate), DESMOPRESSIN, DEGARELIX for injection and EUFLEXXA(R) (1% sodium hyaluronate). Ferring Pharmaceuticals specializes in the research, development and commercialization of compounds in general and pediatric ...New Weight Loss Hope for People with Diabetes
... customizable. The program features more than 140 gourmet-style selections that emphasize healthful whole grains, as well as low fat and low sodium dishes. NutriSystem D menu items are designed to be heart healthy with zero trans fat and low sodium. Customers can supplement their NutriSystem ...Other ContentspigmentpigmentpigmentpigmentpigmentmembranemembranemembranemembranemembranemembranemembranemembranemembranephysiologyphysiologyphysiologyphysiologyphysiologyphysiologyphysiologyplasmidplasmidplasmidplasmidplasmidplasmidplasmidplasmidplantplantplantplantplantplantplantplantplantpolysaccharidepolysaccharidepolysaccharidepolysaccharidepeptidepeptidepeptidepeptidepeptidepeptidepeptidepeptidepeptideOther TagsCurettesAllograftCagesteerable
(Date:11/26/2009)...2009) Whitehead researchers have developed a new ... specific genes and proteins used by pathogens, ac...uman cell cultures genes are present in two copies...other. Gene inactivation by mutation is therefore ...the second copy usually remains active and takes o...
(Date:11/26/2009)...aphylococcus Aureus ) and other drug-resistant bac...lasma prototype devices have been developed to off...cktails. , Two prototype devices have been devel...in (e.g. hands and feet) in hospitals and public s... another to shoot bacteria-killing agents into inf...
(Date:11/25/2009)...the stomach, may be used to boost resistance to, o...le School of Medicine researchers report in a stud...euroscience . , Parkinson,s disease is caused by...the midbrain known as the substantia nigra, which ...roduction of dopamine in late-stage Parkinson,s ca...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Specialty Hospitals of America Accepts First Patients in New Long Term Critical Care Hospital Located in South East Washington 50714 1Specialty Hospitals of America Accepts First Patients in New Long Term Critical Care Hospital Located in South East Washington 50714 2How much is life worth 3F The 24440 billion question 12887 1How much is life worth 3F The 24440 billion question 12887 2Scienceroll com on the Medical Implications of Virtual Worlds 50706 1(Date:11/27/2009)... SHAMIR, Israel, Nov. 27 ...Shamir" ), a leading provider of innovative produc...nnounced today that its board of directors had dec...nt of US$ 10 million (approximately NIS 37.62 mill...rate of exchange), or approximately US$ 0.609 (app...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allrec...cord-high Thanksgiving traffic numbers, with more ...ing, providing a clear picture of what was served ...ge Thanksgiving meal in 2009 weighed in at 2,225 c...t year,s feast. According to the Allrecipes site, ...
(Date:11/27/2009)... Three new interactive anatomy education ap...kins expand health sciences learning opportunities... Durham, NC (Vocus) November 27, 2009 -- Modal...LWW), a division of Wolters Kluwer Health, today a...cation apps on the App Store. Clemente’s Ana...
(Date:11/26/2009)...stering drug tetrathiomolybdate (TM) has been show...ilson disease, a disease caused by an overload of ...is known. Very little, however, is known about how...study led by Northwestern University researchers n...nsional structure of TM bound to copper-loaded met...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Cente...las , is one of a growing number of physicians who...g sites to connect with individuals who are intere...rbid obesity. Dr. Kim is utilizing Facebook to sha...is practice with the community. , ...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3[0] Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend[0] It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store[1] Research sheds light on workings of anti-cancer drug[1] Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients
CurettesDissectorsSpeculaFacetHypophysectomieAVMAllograftCageIntervertebralNeuroendoscopeProximitysteerableGingivoplastyHSM
Other Tagspreviously 2previously 3previously 4previously 5previously 6previously 7previously 8previously 9previously 10flavor 2waves 2waves 3waves 4reading 2reading 3mission 2mission 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |